Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bjerner

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Annals of Clinical Biochemistry|June 29, 2012
Belief is only half the truth--or why screening for heterophilic antibody interference in certain assays makes double senseJohan Bjerner, Nils Bolstad, Armin Piehler
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 12, 2010
[The Swedish Chlamydia mutant nvC trachomatis in Norway]Nils Reinton, Harald Moi, Johan Bjerner, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 23, 2011
Human epididymis protein 4 reference limits and natural variation in a Nordic reference populationNils Bolstad, Miriam Øijordsbakken, Kjell Nustad, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 10, 2002
Serum levels of soluble transferrin receptor correlate with severity of disease but not with iron stores in patients with malignant lymphomasJohan Bjerner, Lise-Marit Amlie, Leiv Sindre Rusten, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 5, 2003
MUC1 serum assays in breast cancer: tumor specificities and reference levelsJohan Bjerner, Lars F Norum, Olle Nilsson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 26, 2009
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP projectJohan Bjerner, Donata Biernat, Sophie D Fosså, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Testing and validating a homogeneous immunometric assay for interferenceJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Biochemistry|April 12, 2005
Human heterophilic antibodies display specificity for murine IgG subclassesJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 11, 2015
Interference of common haemoglobin variants with the Tosoh G7 standard mode HbA1c methodArmin P Piehler, Runa M Grimholt, Johan Bjerner, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 1, 2008
Progastrin-releasing peptide: stability in plasma/serum and upper reference limitMarianne S Nordlund, Johan Bjerner, David J Warren, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Annals of Clinical Biochemistry|June 29, 2012
Belief is only half the truth--or why screening for heterophilic antibody interference in certain assays makes double senseJohan Bjerner, Nils Bolstad, Armin Piehler
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 12, 2010
[The Swedish Chlamydia mutant nvC trachomatis in Norway]Nils Reinton, Harald Moi, Johan Bjerner, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 23, 2011
Human epididymis protein 4 reference limits and natural variation in a Nordic reference populationNils Bolstad, Miriam Øijordsbakken, Kjell Nustad, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 10, 2002
Serum levels of soluble transferrin receptor correlate with severity of disease but not with iron stores in patients with malignant lymphomasJohan Bjerner, Lise-Marit Amlie, Leiv Sindre Rusten, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 5, 2003
MUC1 serum assays in breast cancer: tumor specificities and reference levelsJohan Bjerner, Lars F Norum, Olle Nilsson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 26, 2009
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP projectJohan Bjerner, Donata Biernat, Sophie D Fosså, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Testing and validating a homogeneous immunometric assay for interferenceJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Biochemistry|April 12, 2005
Human heterophilic antibodies display specificity for murine IgG subclassesJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 11, 2015
Interference of common haemoglobin variants with the Tosoh G7 standard mode HbA1c methodArmin P Piehler, Runa M Grimholt, Johan Bjerner, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 1, 2008
Progastrin-releasing peptide: stability in plasma/serum and upper reference limitMarianne S Nordlund, Johan Bjerner, David J Warren, et al.
Pageof 3